Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sodium Oxybate in Treatment-Resistant REM Sleep Behavior Disorder (RBD): A Randomized Placebo-Controlled Trial

NCT04006925 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT04006925
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04006925 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sodium Oxybate in Treatment-Resistant REM Sleep Behavior Disorder (RBD): A Randomized Placebo-Controlled Trial
Lead sponsor
Stanford University
Phase
Phase 4
Overall status
Completed
Start date
September 10, 2019
Completion date
February 1, 2022
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson disease, rem sleep behavior disorder